Find Clinical Trials | Cedars-Sinai

396 results found

Melanoma, Unknown Sites

SWOG, S2101, PhII, open label, Cabozantinib + Nivolumab, Melanoma or HNSCC

Primary Objective: 1. To evaluate the feasibility of molecular characterization based on tumor mutation burden (TMB) for participant stratification, as assessed by the proportion of participants with less than or equal to a 21-day ...

Breast

Tart Cherry and Omega-3 s for Aromatase Inhibitor Musculoskeletal Symptoms

This study focuses on people with breast cancer who have aromatase therapy-associated musculoskeletal symptoms. The purpose of the study is to determine whether tart cherry concentrate and fish oil, when taken together, have an impact ...

Obesity

Evaluating Environmental Control (AVOID) and Inhibitory Control (RESIST) Strategies to Improve Weight Management Outcomes

This study tests strategies to help adults with overweight or obesity (BMI between 25-45 kg/m2) “stick” to weight management recommendations. Specifically, the study evaluates the benefit of 2 self-regulatory approaches to improve intentional weight loss ...

Melanoma

Memorial Sloan Kettering, 24-166 A, Ph2, Melanoma, fianlimab, cemiplimab, and ipilimumab

Primary objectives: 1. Determine best ORR by RECIST v1.1 separately among patients whose melanoma progressed on prior anti-PD-1 monotherapy (Cohort A) and on anti-PD-1 and anti-LAG-3 ICI therapy (Cohort B) Secondary objectives: 1. Assess safety of fianlimab, cemiplimab, ...

Breast

CSMS, IIT2024-09-YUAN-NeoIVO, PhII, open-label, TNBC, Ivonescimab + Carboplatin + docetaxel

Primary Objective: Pathological complete response (pCR) rate Secondary Objectives: Event-free survival (EFS) Overall survival (OS) Patient-reported outcomes (PRO) Immune biomarkers